What is the recommended dosing of Augmentin (amoxicillin-clavulanate) for a patient with a skin infection, considering factors such as severity of infection and renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for Skin Infections

For uncomplicated skin infections in adults, the standard Augmentin dose is 875 mg/125 mg orally every 12 hours, or alternatively 500 mg/125 mg every 8 hours for more severe infections. 1

Adult Dosing

  • Standard dose: 500 mg/125 mg tablet every 12 hours for mild to moderate skin infections 1
  • More severe infections: 875 mg/125 mg tablet every 12 hours OR 500 mg/125 mg tablet every 8 hours 1
  • Duration: Typically 7-10 days depending on clinical response 2
  • Administration: Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal side effects 1

Pediatric Dosing (≥12 weeks/3 months)

  • Standard dose: 25 mg/kg/day divided every 12 hours for less severe infections 1
  • More severe infections: 45 mg/kg/day divided every 12 hours 1
  • Alternative regimen: 40 mg/kg/day divided every 8 hours (though the every 12-hour regimen is preferred due to less diarrhea) 1
  • Children ≥40 kg: Use adult dosing recommendations 1
  • Neonates <12 weeks: 30 mg/kg/day divided every 12 hours 1

Clinical Context and Indications

Augmentin is specifically recommended for animal and human bite wounds where mixed aerobic-anaerobic flora is expected, including Pasteurella multocida from animal bites 2

Appropriate Use:

  • Animal bites: First-line oral agent (875/125 mg twice daily) 2
  • Human bites: First-line oral agent (875/125 mg twice daily) 2
  • Mixed skin infections: Effective against both gram-positive cocci and some gram-negative organisms 3, 4
  • Infected eczema, trauma, or ulcers: Demonstrated 94% response rate in clinical studies 3

Important Limitations:

  • Does NOT cover MRSA: If MRSA is suspected or confirmed, alternative agents (vancomycin, linezolid, clindamycin, TMP-SMX, or doxycycline) must be used 2
  • Some gram-negative resistance: Certain gram-negative rods may be resistant 2

Critical Dosing Warnings

Do NOT substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet - they contain the same amount of clavulanic acid (125 mg) but different amounts of amoxicillin, making them non-equivalent 1

Do NOT interchange different formulations - the 250 mg/125 mg tablet contains 125 mg clavulanic acid while the 250 mg/62.5 mg chewable contains only 62.5 mg clavulanic acid 1

Renal Function Adjustments

While not explicitly detailed in the provided FDA label excerpt, dose adjustment is required for patients with significant renal impairment (this is standard practice for amoxicillin-clavulanate, though specific adjustments should be referenced from complete prescribing information).

Safety Profile

  • Common side effects: Nausea (9%), diarrhea (9%), and rash (3%) 3
  • Generally well-tolerated: Adverse events are typically mild to moderate, primarily involving the digestive system 4, 5
  • Pregnancy: FDA Category B - generally considered safe 6 (though this refers to cephalexin, similar beta-lactams like amoxicillin-clavulanate are also Category B)

Clinical Efficacy

Augmentin demonstrates 76-94% clinical cure rates for skin and soft tissue infections, with particular effectiveness against Staphylococcus aureus (methicillin-susceptible) and Streptococcus pyogenes 3, 4, 5

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.